Anomalies of the genetic complement and its role in C3 Glomerulopathies and development of Hemolithic Uremic Syndrome

  • Juan Esteban Tafur Delgado Second-year Pediatric Resident Of The University Of Sinú
  • Carlos Andrés Pérez Lozano General Medical University Foundation of Health Sciences, Bogotá
  • Lina Marcela Ortiz Roncallo General Medical University Of The Sabana, Bogotá
  • Silvia Juliana Rodríguez Pérez Intern At The University Of Sinú, Montería
  • Amaury Gustavo López Agámez Intern At The University Of Sinú, Montería
  • María José Álvarez Gómez Intern At The University Of Sinú, Montería
  • Ricardo Javier Galván Zúñiga Intern At The University Of Sinú, Montería
  • Ana María Garcés Pérez General Medical Of The University Of Magdalena
Keywords: genetic complement anomalies, glomerulopathy, active C3

Abstract

Let us remember that C3 glomerulopathy is the product of an abnormal activation in the alternative complement pathway, which leads to an excessive production of active C3 and its degradation products

Downloads

Download data is not yet available.

References

1. Servais A, Noël L, Roumenina L, Le Quintrec M, Ngo S, Dragon-Durey M et al. Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies. Kidney International. 2012;82(4):454-464.
2. Taborda-MurilloA, Arroyave-SuárezMJ, Arias-RestrepoLF. Glomerulonefritis C3: una nueva categoría de glomerulonefritis con implicaciones etiopatogénicas. Iatreia [Internet]. 29 de diciembre de 2015 [citado 10 de marzo de 2021];28(1): Pág. 24-34. Disponible en:https://revistas.udea.edu.co/index.php/iatreia/article/view/17580
3. Cook H, Pickering M. Histopathology of MPGN and C3 glomerulopathies. Nature Reviews Nephrology. 2015;11(1):14-22.
4. Iatropoulos P, Daina E, Curreri M, Piras R, Valoti E, Mele C et al. Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex–Mediated Membranoproliferative GN. Journal of the American Society of Nephrology. 2017;29(1):283-294.
5. Häffner, K., Michelfelder, S. & Pohl, M. Tratamiento exitoso de la glomerulopatía C3 positiva para C3Nef con terapia de plasma e inmunosupresión. Pediatr Nephrol 30, 1951-1959 (2015). https://doi.org/10.1007/s00467-015-3111-9
How to Cite
1.
Delgado JET, Lozano CAP, Roncallo LMO, Pérez SJR, Agámez AGL, Gómez MJ Álvarez, Zúñiga RJG, Pérez AMG. Anomalies of the genetic complement and its role in C3 Glomerulopathies and development of Hemolithic Uremic Syndrome. Med. res. chronicles [Internet]. 2021Jul.20 [cited 2021Oct.25];8(4):303-4. Available from: https://www.medrech.com/index.php/medrech/article/view/516
Section
Editorial Note